Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Net Cash Flow data on file, last reported at -$10.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 25.77% year-over-year to -$10.9 million; the trailing twelve-month figure through Mar 2026 stood at $49.9 million (up 123.67% YoY), and the FY2025 full-year result was $46.1 million, up 79.64% from the prior year.
• Net Cash Flow retreated to -$10.9 million in Q1 2026, from $34.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $61.5 million in Q4 2024 to a low of -$14.7 million in Q1 2025.
• A 4-year average of $4.9 million and a median of -$10.6 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 608.82% in 2024 and tumbled 43.37% in 2025, its largest moves.
• Tracing CAMP's Net Cash Flow over 4 years: stood at -$12.1 million in 2023, then jumped by 608.82% to $61.5 million in 2024, then sank by 43.37% to $34.8 million in 2025, then plunged by 131.36% to -$10.9 million in 2026.
• Business Quant data shows CAMP's Net Cash Flow at -$10.9 million in Q1 2026, $34.8 million in Q4 2025, and $36.2 million in Q3 2025.